[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100558866":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":25,"locations":35,"responsibleParty":90,"collaborators":11,"id":92,"slug":93,"hasResults":94,"nctId":95,"briefTitle":96,"officialTitle":97,"acronym":11,"eligibilityCriteria":98,"healthyVolunteers":94,"sex":99,"minAge":100,"maxAge":11,"enrollmentInfo":101,"targetDuration":11,"studyType":104,"phases":105,"briefSummary":107,"conditions":108,"keywords":11,"overallStatus":38,"whyStopped":11,"lastUpdateSubmitDate":110,"lastUpdatePostDateStruct":111,"startDateStruct":114,"completionDateStruct":116,"leadSponsor":118,"locationsCount":119},{"fullName":5,"class":6},"Zoll Medical Corporation","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention group","EXPERIMENTAL",null,[13],"Device: Dual Channel Stimulation",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":11},"DEVICE","Dual Channel Stimulation","implant of dual channel stimulation device",[9],[21],{"name":22,"affiliation":23,"role":24},"Robin Germany, MD","ZOLL Respicardia","STUDY_DIRECTOR",[26,31],{"name":27,"role":28,"phone":29,"phoneExt":11,"email":30},"Samuel Kolapo","CONTACT","205-441-9519","samuel.kolapo@zoll.com",{"name":32,"role":28,"phone":33,"phoneExt":11,"email":34},"Kathy McPherson","615-613-6321","kmcpherson@zoll.com",[36,58,74],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"The Insomnia and Sleep Institute of Arizona LLC","RECRUITING","Scottsdale","Arizona","85255","United States","US",{"type":45,"coordinates":46},"Point",[47,48],-111.89903,33.50921,{"lat":48,"lon":47},[51,55],{"name":52,"role":28,"phone":53,"phoneExt":11,"email":54},"Shelley Beaver, RC","480-745-3547","research@sleeplessinarizona.com",{"name":56,"role":57,"phone":11,"phoneExt":11,"email":11},"Sriharsha Vajjala, MD","PRINCIPAL_INVESTIGATOR",{"facility":59,"status":38,"city":60,"state":61,"zip":62,"country":42,"countryCode":43,"cosmosGeoPoint":63,"geoPoint":67,"contacts":68},"The University of Michigan Health-West","Wyoming","Michigan","49519",{"type":45,"coordinates":64},[65,66],-85.70531,42.91336,{"lat":66,"lon":65},[69,72],{"name":70,"role":28,"phone":11,"phoneExt":11,"email":71},"Stefanie Davis","Stefanie.Davis@umhwest.org",{"name":73,"role":57,"phone":11,"phoneExt":11,"email":11},"Timothy Daum, MD",{"facility":75,"status":38,"city":76,"state":77,"zip":78,"country":42,"countryCode":43,"cosmosGeoPoint":79,"geoPoint":83,"contacts":84},"The Ohio State University","Columbus","Ohio","43210",{"type":45,"coordinates":80},[81,82],-82.99879,39.96118,{"lat":82,"lon":81},[85,88],{"name":86,"role":28,"phone":11,"phoneExt":11,"email":87},"Kalyn Ferguson","Kalyn.Ferguson@osumc.edu",{"name":89,"role":57,"phone":11,"phoneExt":11,"email":11},"Ralph Augostini, MD",{"type":91,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100558866","janus-ii-feasibility-100558866",false,"NCT06556693","Janus II Feasibility","Janus II: A Feasibility Study to Evaluate Response to Remede Dual Channel System Therapy","Inclusion Criteria:\n\n* Severe sleep disordered breathing\n* Expected to tolerate study procedures\n* No heart failure or medically stable heart failure\n\nExclusion Criteria:\n\n* Currently implanted with a neurostimulator to treat sleep disordered breathing without sponsor approval\n* History of severe COPD or pulmonary arterial hypertension\n* Current or previous history of nerve injury or palsy\n* Prior cervical surgeries or radiation treatment to head region\n* Known need for an MRI\n* History of psychosis or severe bipolar disorder\n* Active Infection or sepsis within 30 days of enrollment\n* Currently on kidney dialysis or significantly reduced kidney function\n* Hemoglobin less than 8g\u002Fdl\n* Pacemaker dependance\n* New defibrillator or any implantable device or device generator changeout within 30 days prior to study implant or anticipated within the first 12 months\n* Other conditions or anticipated surgical procedure expected to affect ability to complete study procedures\n* Allergy to contrast dye unless can be prophylactically treated\n* Known pregnancy or planning to become pregnant","ALL","22 Years",{"count":102,"type":103},40,"ESTIMATED","INTERVENTIONAL",[106],"NA","The objectives of this study are to evaluate the feasibility of the remedē® Dual Channel System at implant and overnight sleep studies and to assess chronic safety.",[109],"Sleep Apnea","2025-10-28",{"date":112,"type":113},"2025-10-29","ACTUAL",{"date":115,"type":113},"2025-08-12",{"date":117,"type":103},"2034-12",{"name":5,"class":6},3]